Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 4,210,000 shares, a growth of 50.4% from the August 31st total of 2,800,000 shares. Based on an average trading volume of 1,120,000 shares, the short-interest ratio […]
Los Angeles Capital Management LLC raised its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) by 248.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 238,125 shares of the biopharmaceutical company’s stock after buying an additional 169,768 shares during the quarter. Los […]
Victory Capital Management Inc. increased its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Rating) by 6.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 292,240 shares of the biopharmaceutical company’s stock after purchasing an additional 18,325 shares during the quarter. Victory Capital Management […]